Peter E. Crossen

1.3k total citations
46 papers, 1.1k citations indexed

About

Peter E. Crossen is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Peter E. Crossen has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Cancer Research and 12 papers in Genetics. Recurrent topics in Peter E. Crossen's work include Carcinogens and Genotoxicity Assessment (18 papers), DNA Repair Mechanisms (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Peter E. Crossen is often cited by papers focused on Carcinogens and Genotoxicity Assessment (18 papers), DNA Repair Mechanisms (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Peter E. Crossen collaborates with scholars based in New Zealand, United States and Uruguay. Peter E. Crossen's co-authors include William F. Morgan, F. W. Gunz, P. H. Fitzgerald, F Arrighi, Dennis A. Johnston, Máximo E. Drets, Paul Vincent, D. C. Heaton, Sen Pathak and J. Hamer and has published in prestigious journals such as Blood, Cancer and The American Journal of Medicine.

In The Last Decade

Peter E. Crossen

46 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter E. Crossen New Zealand 20 496 377 212 185 177 46 1.1k
U Haglund Sweden 10 357 0.7× 166 0.4× 311 1.5× 139 0.8× 180 1.0× 16 1.1k
Jan C. Liang United States 25 680 1.4× 395 1.0× 106 0.5× 460 2.5× 263 1.5× 55 1.7k
Sylvie Galiègue‐Zouitina France 17 749 1.5× 151 0.4× 313 1.5× 284 1.5× 86 0.5× 41 1.3k
H Hirai Japan 16 596 1.2× 114 0.3× 164 0.8× 227 1.2× 55 0.3× 36 1.1k
Annahita Sallmyr United States 13 957 1.9× 179 0.5× 89 0.4× 143 0.8× 109 0.6× 26 1.3k
Benjamin J. Thompson United States 11 901 1.8× 191 0.5× 97 0.5× 222 1.2× 96 0.5× 22 1.3k
Tsz Kan Fung Hong Kong 21 1.5k 3.0× 308 0.8× 177 0.8× 98 0.5× 102 0.6× 29 1.9k
Kwan Yeung Wong Hong Kong 23 1.0k 2.0× 812 2.2× 90 0.4× 105 0.6× 65 0.4× 37 1.4k
Denise Howe United Kingdom 12 845 1.7× 195 0.5× 121 0.6× 154 0.8× 58 0.3× 21 1.2k

Countries citing papers authored by Peter E. Crossen

Since Specialization
Citations

This map shows the geographic impact of Peter E. Crossen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Crossen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Crossen more than expected).

Fields of papers citing papers by Peter E. Crossen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Crossen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Crossen. The network helps show where Peter E. Crossen may publish in the future.

Co-authorship network of co-authors of Peter E. Crossen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Crossen. A scholar is included among the top collaborators of Peter E. Crossen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Crossen. Peter E. Crossen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crossen, Peter E., et al.. (1999). Identification of Amplified Genes in a Patient with Acute Myeloid Leukemia and Double Minute Chromosomes. Cancer Genetics and Cytogenetics. 113(2). 126–133. 34 indexed citations
2.
Crossen, Peter E., et al.. (1999). Methylation status of the 3rd exon of the c-MYC oncogene in B-cell malignancies. Leukemia Research. 23(3). 251–253. 9 indexed citations
3.
Crossen, Peter E., et al.. (1998). Aberrant Rearrangements of the Immunoglobulin Heavy Chain Switch Region in Chronic B-Cell Leukemia. Leukemia & lymphoma. 31(5-6). 559–565. 5 indexed citations
4.
Crossen, Peter E., et al.. (1998). Hypermethylation of the M27β (DXS255) locus in chronic B‐cell leukaemia. British Journal of Haematology. 100(1). 191–193. 5 indexed citations
5.
Crossen, Peter E., et al.. (1996). Elevated frequency of the C2 allele of the ETS-I oncogene in elderly subjects. Mechanisms of Ageing and Development. 88(1-2). 61–65. 2 indexed citations
6.
Crossen, Peter E., et al.. (1995). Elevated frequency of a SstI polymorphism of the Ets-1 oncogene in non-Hodgkin's lymphoma patients. Cancer Genetics and Cytogenetics. 79(1). 70–73. 1 indexed citations
7.
Crossen, Peter E., et al.. (1993). Lack of 5′ BCL2 rearrangements in B-cell leukemia. Cancer Genetics and Cytogenetics. 69(1). 72–73. 8 indexed citations
8.
Crossen, Peter E., et al.. (1993). Cloning and sequencing of a t(14;19) breakpoint that involves the Cμ switch region. Genes Chromosomes and Cancer. 8(1). 60–62. 18 indexed citations
9.
Crossen, Peter E., et al.. (1991). Complex karyotypic evolution in B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics. 57(2). 187–194. 12 indexed citations
10.
Morris, Christine M., et al.. (1991). Molecular Definition of Interstitial Deletions of Chromosome 13 in Leukemic Cells. Genes Chromosomes and Cancer. 3(6). 455–460. 28 indexed citations
11.
Carter, John, et al.. (1990). t(2;14)(q23;q32.3) as the sole abnormality in a patient with acute nonlymphocytic leukemia (FAB-M4). Cancer Genetics and Cytogenetics. 48(2). 255–257. 2 indexed citations
12.
Crossen, Peter E.. (1989). Cytogenetic and molecular changes in chronic B-cell leukemia. Cancer Genetics and Cytogenetics. 43(2). 143–150. 29 indexed citations
13.
Crossen, Peter E., et al.. (1986). Generation time (GT) of human bone marrow cells cultured in the CFC‐gm assay. Cell Proliferation. 19(5). 533–538. 5 indexed citations
14.
Crossen, Peter E.. (1985). The effect of temperature and cell cycle length on SCE frequency in Rat-1 cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 149(1). 101–104. 3 indexed citations
15.
Crossen, Peter E. & William F. Morgan. (1982). The effect of chlorpromazine on SCE frequency in human chromosomes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 96(2-3). 225–232. 11 indexed citations
16.
Morgan, William F. & Peter E. Crossen. (1980). X irradiation and sister chromatid exchange in cultured human lymphocytes. Environmental Mutagenesis. 2(2). 149–155. 48 indexed citations
17.
Crossen, Peter E. & William F. Morgan. (1979). The effects of ß-radiation on sister-chromatid exchanges in cultured human lymphocytes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 62(1). 125–129. 13 indexed citations
18.
Morgan, William F. & Peter E. Crossen. (1977). The incidence of sister chromatid exchanges in cultured human lymphocytes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 42(2). 305–311. 94 indexed citations
19.
Morgan, William F. & Peter E. Crossen. (1977). The frequency and distribution of sister chromatid exchanges in human chromosomes. Human Genetics. 38(3). 271–278. 33 indexed citations
20.
Fitzgerald, P. H., Peter E. Crossen, & J. Hamer. (1973). Abnormal karyotypic clones in human acute leukemia: Their nature and clinical significance. Cancer. 31(5). 1069–1077. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026